PYC — PYC Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$1.85bn
- AU$1.40bn
- AU$39.68m
Annual cashflow statement for PYC Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 6.1 | 9.74 | 21.3 | 20.1 | 30.7 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -21.8 | -24.4 | -38.6 | -51.6 | -44.5 |
| Capital Expenditures | -0.387 | -0.491 | -0.307 | -0.975 | -0.531 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 33.1 | 0.014 | 0 | — | -616 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 32.7 | -0.477 | -0.307 | -0.975 | -616 |
| Financing Cash Flow Items | 0 | -0.976 | -1.57 | -6.8 | -36.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.182 | 11.4 | 90.2 | 139 | 563 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.7 | -13.5 | 51.3 | 86.2 | -99.5 |